Advanced AI Solutions for Research & Pharmaceutical Applications
PanCancer AI Modules & Foundation Models
Multi-modal capability for research and pharmaceutical applications with advanced AI models for cancer analysis.
Generate comprehensive clinical reports
Detect and classify cancer subtypes
Predict genomic biomarkers with minimal data
Virchow variants (Up to 1.8 billion parameters, 40 tissue types)
Zero-shot detection capabilities
Paige Alba™ (Beta)
Pathology AI co-pilot that integrates pathology, radiology, and clinical data into a single AI-powered experience.
PRISM technology covering 16 tissue types
Slide-level analysis with high precision
Automatic clinical report generation
Comprehensive cancer detection and subtyping
Paige OmniScreen™
AI-driven approach to pre-screening for clinically relevant biomarkers. Enables study participant selection, more efficient testing strategies, and streamlined decision-making.
Detect 1,600+ biomarkers from H&E slides alone
Predicts genomic alterations in 491 genes across multiple cancers
Life Sciences & Research Pricing: Pharma SDK pricing ranges from $100k-500k per year. Foundation models and AI modules are available with custom pricing for research and pharmaceutical partners. Estimated savings of US $200k–500k per Phase II/III study via faster slide review & biomarker stratification.